FMFMX
Price
$18.25
Change
+$0.41 (+2.30%)
Updated
Oct 13 closing price
Net Assets
1.44B
RGACX
Price
$84.96
Change
+$1.64 (+1.97%)
Updated
Oct 13 closing price
Net Assets
338.36B
Interact to see
Advertisement

FMFMX vs RGACX

Header iconFMFMX vs RGACX Comparison
Open Charts FMFMX vs RGACXBanner chart's image
Fidelity Advisor Series Equity Gr
Price$18.25
Change+$0.41 (+2.30%)
VolumeN/A
Net Assets1.44B
American Funds Growth Fund of Amer R3
Price$84.96
Change+$1.64 (+1.97%)
VolumeN/A
Net Assets338.36B
FMFMX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
FMFMX vs. RGACX commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMFMX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 338B vs. FMFMX (1.44B). FMFMX pays higher dividends than RGACX: FMFMX (0.48) vs RGACX (0.07). FMFMX was incepted earlier than RGACX: FMFMX (11 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than FMFMX (0.01). FMFMX is a more actively managed with annual turnover of: 67.00 vs. RGACX (25.00). FMFMX has a lower initial minimum investment than RGACX: FMFMX (0) vs RGACX (250). RGACX annual gain was more profitable for investors over the last year : 11.09 vs. FMFMX (-11.44). RGACX return over 5 years is better than : 37.25 vs. FMFMX (-3.62).
FMFMXRGACXFMFMX / RGACX
Total Expense Ratio0.010.941%
Annual Report Gross Expense Ratio0.010.941%
Fund Existence11 years23 years-
Gain YTD12.13118.01667%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.44B338B0%
Annual Yield % from dividends0.480.07694%
Returns for 1 year-11.4411.09-103%
Returns for 3 years51.4278.1766%
Returns for 5 years-3.6237.25-10%
Returns for 10 years69.4096.6672%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DK34.091.78
+5.51%
Delek US Holdings
ENVB0.650.02
+3.33%
Enveric Biosciences Inc
DAVA8.390.08
+0.96%
Endava plc
BAX22.110.16
+0.73%
Baxter International
MHH7.03-0.06
-0.85%
Mastech Digital